AVR 2.00% $11.76 anteris technologies ltd

Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular, page-18

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,240 Posts.
    lightbulb Created with Sketch. 253
    So pleased for holders. I was convinced you'd done your dough. Obviously still a spec but geez it was a 100% loss if this deal didn't happen so it's a wonderful result for holders in that sense. SP a bit nowhere but better than losing the lot! V happy to have been wrong.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.